For musculoskeletal injuries, this might include range of motion testing, strength assessments, or imaging follow-up
If patients do not tolerate the maintenance 2.4 mg once-weekly dose, the dose can be temporarily decreased to 1.7 mg once-weekly, for a maximum of 4 weeks
Retrieved 20 January 2025
Tracking progress beyond the scale Looking at body composition changes, energy levels, how clothes fit, and overall strength can provide a more complete picture than weight alone
This suggests these drugs could have a direct way of lowering brain pressure, completely independent of weight loss
Chronic Spontaneous Urticaria Adults and Pediatric Subjects 12 Years of Age and Older with CSU The pooled safety data below reflects the safety of DUPIXENT in adult and pediatric subjects 12 years of age and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment